ATE267613T1 - Arzneimittel und deren verwendung - Google Patents
Arzneimittel und deren verwendungInfo
- Publication number
- ATE267613T1 ATE267613T1 AT99909085T AT99909085T ATE267613T1 AT E267613 T1 ATE267613 T1 AT E267613T1 AT 99909085 T AT99909085 T AT 99909085T AT 99909085 T AT99909085 T AT 99909085T AT E267613 T1 ATE267613 T1 AT E267613T1
- Authority
- AT
- Austria
- Prior art keywords
- medicinal products
- composition
- micelle
- delivering
- provides
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9804705.3A GB9804705D0 (en) | 1998-03-05 | 1998-03-05 | Pharmaceutical compositions and their use |
GBGB9827835.1A GB9827835D0 (en) | 1998-03-05 | 1998-12-17 | Pharmaceutical compositions and their use |
PCT/GB1999/000656 WO1999044642A1 (en) | 1998-03-05 | 1999-03-05 | Pharmaceutical compositions and their use |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE267613T1 true ATE267613T1 (de) | 2004-06-15 |
Family
ID=26313227
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99909085T ATE267613T1 (de) | 1998-03-05 | 1999-03-05 | Arzneimittel und deren verwendung |
Country Status (7)
Country | Link |
---|---|
US (1) | US6605298B1 (de) |
EP (1) | EP1059941B1 (de) |
JP (1) | JP2002505307A (de) |
AT (1) | ATE267613T1 (de) |
AU (1) | AU2845599A (de) |
DE (1) | DE69917609T2 (de) |
WO (1) | WO1999044642A1 (de) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9908309D0 (en) * | 1999-04-12 | 1999-06-02 | Phares Pharm Res Nv | Lipid aggregate forming compositions and their use |
EP1408930A1 (de) * | 1999-10-20 | 2004-04-21 | Vesifact Ag | Cyclosporine enthaltende mikroemulsion-prekonzentrate und mikroemulsionen |
DE10026699A1 (de) * | 2000-05-30 | 2001-12-06 | Basf Ag | Formulierung auf Heparin-, Glycosaminoglycan- oder Heparinoidbasis und Verwendung der Formulierung sowie der Formulierungsgrundlage |
AU2002345322B2 (en) * | 2001-06-26 | 2008-06-19 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Compositions and methods for intracellular delivery |
US20050232996A1 (en) * | 2002-04-19 | 2005-10-20 | Dirk Cremer | Matrix comprising a bioactive component containing phospholipid |
US7306819B2 (en) | 2002-06-12 | 2007-12-11 | The Coca-Cola Company | Beverages containing plant sterols |
KR101153459B1 (ko) | 2002-06-12 | 2012-06-07 | 더 코카콜라 컴파니 | 식물성 스테롤을 함유하는 음료 |
KR20070008720A (ko) * | 2004-05-06 | 2007-01-17 | 에미스페어 테크놀로지스, 인코포레이티드 | 습윤 헤파린의 고체 투여형 |
CA2565188C (en) | 2004-05-14 | 2014-03-04 | Emisphere Technologies, Inc. | Compounds and compositions for delivering active agents |
WO2005110360A2 (en) * | 2004-05-18 | 2005-11-24 | Phares Pharmaceutical Research N.V. | Compositions for injection |
US20080171687A1 (en) * | 2004-09-16 | 2008-07-17 | Abraxis Bioscience, Inc. | Compositions And Methods For The Preparation And Administration Of Poorly Water Soluble Drugs |
JPWO2008041553A1 (ja) | 2006-09-26 | 2010-02-04 | アステラス製薬株式会社 | タクロリムス徐放性製剤 |
US20090011018A1 (en) | 2006-12-28 | 2009-01-08 | Astellas Pharma Inc., | Sustained release formulation for tacrolimus |
EP2207570A2 (de) | 2007-09-14 | 2010-07-21 | Nitto Denko Corporation | Arzneimittelträger |
WO2010010470A2 (en) * | 2008-07-23 | 2010-01-28 | Tdt, Ltd | Methods of administering topical antifungal formulations for the treatment of fungal infections |
EP2151231B1 (de) * | 2008-08-05 | 2017-08-02 | PM-International AG | Kosmetische Formulierung |
US20120064143A1 (en) | 2008-11-11 | 2012-03-15 | The Board Of Regents Of The University Of Texas System | Inhibition of mammalian target of rapamycin |
US20110269704A1 (en) * | 2009-07-24 | 2011-11-03 | Seigfried Bernd G | Method for developing a liquid composition to be applied to the skin as a foam and a composition that can be applied topically |
US9283211B1 (en) | 2009-11-11 | 2016-03-15 | Rapamycin Holdings, Llc | Oral rapamycin preparation and use for stomatitis |
WO2015103447A1 (en) | 2013-12-31 | 2015-07-09 | Rapamycin Holdings, Llc | Oral rapamycin nanoparticle preparations and use |
CN102665401A (zh) | 2009-11-16 | 2012-09-12 | 益普生制药股份有限公司 | 黑皮质素受体配体的药物组合物 |
JP5207420B2 (ja) | 2009-12-25 | 2013-06-12 | 株式会社ケムジェネシス | 低粘度液晶化合物 |
TWI438009B (zh) * | 2010-02-19 | 2014-05-21 | Teikoku Pharma Usa Inc | 紫杉烷前-乳劑調配物及其製造與使用之方法 |
ES2579941T3 (es) * | 2010-03-15 | 2016-08-17 | Ipsen Pharma S.A.S. | Composiciones farmacéuticas de ligandos del receptor de secretagogos de la hormona del crecimiento |
EA027666B1 (ru) | 2010-05-03 | 2017-08-31 | ТЕИКОКУ ФАРМА ЮСЭй, ИНК. | Неводные лекарственные средства в форме проэмульсии на основе таксанов и способы их приготовления и использования |
JO3685B1 (ar) | 2012-10-01 | 2020-08-27 | Teikoku Pharma Usa Inc | صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها |
DK2968281T3 (da) | 2013-03-13 | 2020-11-02 | Univ Texas | Mtor-hæmmere til forebyggelse af vækst af tarmpolyp |
US9700544B2 (en) | 2013-12-31 | 2017-07-11 | Neal K Vail | Oral rapamycin nanoparticle preparations |
US10588866B2 (en) | 2014-11-11 | 2020-03-17 | Verdure Sciences | Stable solid lipid particle composition for improved bioavailability of lipophilic compounds for age-related diseases |
CN104473914B (zh) * | 2015-01-06 | 2017-01-11 | 天津红日药业股份有限公司 | 一种磺酰胺类药物组合物 |
KR101905010B1 (ko) | 2016-04-19 | 2018-10-08 | 앱티스 주식회사 | 코엔자임 q10 가용화 조성물 및 이의 제조방법 |
CN110636863A (zh) * | 2017-05-18 | 2019-12-31 | 丘比株式会社 | 具有自乳化性的组合物及其制造方法及纳米乳液及其制造方法 |
US10716774B1 (en) * | 2018-01-05 | 2020-07-21 | Yale Pharmaceuticals LLC | Pharmaceutical compositions containing isotretinoin with improved dissolution profile and enhanced stability |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB505983A (en) * | 1937-11-17 | 1939-05-17 | Ig Farbenindustrie Ag | Improvements in the manufacture and production of pharmaceutically active substances |
FR2374910A1 (fr) * | 1976-10-23 | 1978-07-21 | Choay Sa | Preparation a base d'heparine, comprenant des liposomes, procede pour l'obtenir et medicaments contenant de telles preparations |
DE3585967D1 (de) * | 1984-03-08 | 1992-06-11 | Phares Pharma Holland | Liposombildende zusammensetzung. |
US5141674A (en) * | 1984-03-08 | 1992-08-25 | Phares Pharmaceutical Research N.V. | Methods of preparing pro-liposome dispersions and aerosols |
DE3613799C1 (de) | 1986-04-24 | 1987-09-03 | Nattermann A & Cie | Verwendung von Glycofurol zum Verfluessigen von Arzneimittelzubereitungen fuer das Abfuellen in Weichgelatinekapseln |
US5009956A (en) * | 1987-02-24 | 1991-04-23 | Univ Minnesota | Phospholipase A2-resistant liposomes |
US5178875A (en) * | 1991-01-14 | 1993-01-12 | The Board Of Regents, The University Of Texas System | Liposomal-polyene preliposomal powder and method for its preparation |
US5043164A (en) * | 1989-01-17 | 1991-08-27 | The University Of Tennessee Research Corporation | Blood-stable, cholesterol-free liposomes |
GB9108043D0 (en) | 1991-04-16 | 1991-06-05 | Phares Pharm Res Nv | Method for the formation of liposomes and compositions for use therein |
DE19609538A1 (de) * | 1996-03-11 | 1997-09-18 | Basf Ag | Feinverteilte Carotinoid- und Retinoidsuspensionen und Verfahren zu ihrer Herstellung |
AU6833994A (en) * | 1993-05-17 | 1994-12-12 | Liposome Company, Inc., The | Incorporation of taxol into liposomes and gels |
GB2315216B (en) | 1993-10-05 | 1998-10-14 | Ciba Geigy Ag | Microemulsion preconcentrates comprising FK506 or 33-epi-chloro-33-desoxy-ascomycin |
ATE317397T1 (de) * | 1993-11-17 | 2006-02-15 | Athena Neurosciences Inc | Transparente flüssigkeit zur verabreichung von verkapselten medikamenten |
SE9601677D0 (sv) * | 1996-05-02 | 1996-05-02 | Scotia Lipidteknik Ab | New use |
WO1998002184A1 (de) * | 1996-07-13 | 1998-01-22 | Mika Pharma Gesellschaft Für Die Entwicklung Und Vermarktung Pharmazeutischer Produkte Mbh | Topische phospholipidhaltige aciclovirzubereitung |
GB2326337A (en) * | 1997-06-20 | 1998-12-23 | Phares Pharma Holland | Homogeneous lipid compositions for drug delivery |
-
1999
- 1999-03-05 AU AU28455/99A patent/AU2845599A/en not_active Abandoned
- 1999-03-05 EP EP99909085A patent/EP1059941B1/de not_active Expired - Lifetime
- 1999-03-05 JP JP2000534242A patent/JP2002505307A/ja not_active Withdrawn
- 1999-03-05 WO PCT/GB1999/000656 patent/WO1999044642A1/en active IP Right Grant
- 1999-03-05 DE DE69917609T patent/DE69917609T2/de not_active Expired - Fee Related
- 1999-03-05 AT AT99909085T patent/ATE267613T1/de not_active IP Right Cessation
-
2000
- 2000-09-05 US US09/655,476 patent/US6605298B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1059941A1 (de) | 2000-12-20 |
JP2002505307A (ja) | 2002-02-19 |
US6605298B1 (en) | 2003-08-12 |
EP1059941B1 (de) | 2004-05-26 |
AU2845599A (en) | 1999-09-20 |
DE69917609T2 (de) | 2005-06-09 |
DE69917609D1 (de) | 2004-07-01 |
WO1999044642A1 (en) | 1999-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE267613T1 (de) | Arzneimittel und deren verwendung | |
ATE163042T1 (de) | Lactobazillusstämme menschlichen ursprungs, ihre zusammensetzung und deren verwendung | |
DE69606028T2 (de) | Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzung | |
IL163552A (en) | Conjugates of biologically active compounds, uses thereof and pharmaceutical compositions comprising the same | |
HUP9601566A3 (en) | Therapeutic tetrahydro-isoquinolin derivatives, their intermediates and pharmaceutical compositions containing the active component | |
DE69630145D1 (de) | Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen | |
NO981746L (no) | Utlevering av biologisk aktive polypeptider | |
NO953278D0 (no) | Fremgangsmåter for in vivo-levering av biologisk aktive stoffer og sammensetninger som er nyttige for dette | |
FI973828A (fi) | Yhdisteitä ja koostumuksia aktiivisten aineiden annostelemiseksi | |
DE69931925D1 (de) | 2-chinolonen enthaltende arzneimittel | |
DE59907961D1 (de) | Indeno-, naphtho- und benzocyclohepta-dihydrothiazol derivate, deren herstellung und deren verwendung als anorektische arzneimittel | |
ID23806A (id) | Komposisi-komposisi farmasi untuk pemberian oral yang terdiri dari bahan aktif dan siklodekstrin | |
DE69815094D1 (de) | 2-(iminoethyl)-aminophenyl - derivate, deren herstellung, deren verwendung als medikamente und diese enthaltende pharmazeutische zubereitungen | |
ATE226947T1 (de) | 2-substituierte 1,2,5-thiadiazolidin-3-on-1,1- dioxiden, zusammensetzung und deren verwendung | |
ATE215373T1 (de) | 21-hydro-6,19-oxidoprogesterone (21oh-60p) und deren verwendung als arzneimittel zur behandlung von glukokortikoidüberschuss | |
DE50003761D1 (de) | Indeno-dihydrothiazol derivate, deren herstellung und deren verwendung als anorektische arzneimittel | |
DE69608680T2 (de) | Taxal derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen | |
DE69610085D1 (de) | Taxol derivate,deren herstellung und diese enthaltende pharmazeutische zusammenstellungen | |
ATE226065T1 (de) | Feste instant-release-darreichungsformen und verfahren zu ihrer herstellung | |
HUP0104238A3 (en) | Benzoxazole derivatives and drugs containing the same as the active ingredient and their use | |
AR015190A1 (es) | Un polimorfo cristalino de 1,3-diciclopropilmetil-8-aminoxantina, procedimiento para su preparacion, composiciones farmaceuticas que lo contienen y su usopara la manufactura de un medicamento | |
DE69914472D1 (de) | Levosimendanhaltige oral anzuwendende arzneimittel mit gesteuerter wirkstoffverabreichung | |
TR199901237T2 (xx) | Bir tienilsiklohegzilamin t�revinin tedavide yeni uygulamas�. | |
DE69719190D1 (de) | Kolostrum enthaltende pharmazeutische zusammensetzungen und deren verwendung | |
UY26510A1 (es) | " biblioteca de sustancias, procedimiento para su preparación y el uso de esta biblioteca de sustancias para la investigación de sustancias activas." |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |